UK - Avon pension fund could become lead plaintiff in a US class action lawsuit against GlaxoSmithKline.
The debacle flared up after a class action suit was filed in the United States District Court for the Southern District of New York against GlaxoSmithKline (GSK) for investors who purchased GSK sec...
To continue reading this article...
Join Professional Pensions
- Unlimited access to real-time news, analysis and opinion from the industry
- Receive our in-depth monthly magazine in either print or digital format
- Access our Sustainable Investment Hub covering news and opinion from thought leaders in the ESG space
- Receive important and breaking news stories selected by the Editors in our daily newsletter
- Hear from industry experts and other forward-thinking leaders
- Receive a monthly members-only newsletter with exclusive opinion pieces from leading industry experts and a feature from the magazine in advance of its release date